Question 1

What is STORM Therapeutics?

Accepted Answer

STORM Therapeutics is a Entity.

Question 2

How often does STORM Therapeutics appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 7 articles.

Question 3

When was STORM Therapeutics first tracked by Ergen?

Accepted Answer

First tracked on Apr 16, 2026.

Question 4

When was STORM Therapeutics last mentioned in news?

Accepted Answer

Last active on May 14, 2026.

Question 5

What is STORM Therapeutics's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is STORM Therapeutics in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving STORM Therapeutics?

Accepted Answer

STORM Therapeutics Secures $56M Financing (Apr 16, 2026, 7 articles).

Question 8

How did the "STORM Therapeutics Secures $56M Financing" event impact STORM Therapeutics?

Accepted Answer

STORM Therapeutics successfully secured $56 million in Series C financing and advanced its lead candidate, STC-15, into Phase 2 clinical trials for sarcoma, indicating significant progress in its cancer therapy development.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.